UMEC/VI

DRUG4 trials

Sponsors

GlaxoSmithKline

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 3

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02152605

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-09-01End: 2015-03-05Updated: 2017-11-09

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

CompletedNCT02257385

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-10-15End: 2015-05-04Updated: 2018-03-01

Phase 4

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

CompletedNCT02799784

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2016-07-14End: 2017-04-27Updated: 2018-07-02

Unknown Phase

Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness

CompletedNCT03543176

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2018-05-31End: 2019-08-21Updated: 2020-08-05

Related Papers

Cost-Effectiveness of Umeclidinium/Vilanterol Versus Indacaterol/Glycopyrronium in Symptomatic patients with COPD in the UK

2023-09-09

Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

Pulmonary Therapy2018-06-1318 citations

P275 Comparing clinically relevant improvement with umeclidinium/vilanterol and tiotropium/olodaterol in symptomatic copd: a randomised non-inferiority crossover trial

2017-11-15

P275 Comparing clinically relevant improvement with umeclidinium/vilanterol and tiotropium/olodaterol in symptomatic copd: a randomised non-inferiority crossover trial

2017-11-15

Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study.

2017-11-0156 citations

Inhaler preference comparing two alternative dual bronchodilator regimens

2016-09-01

Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.

2016-06-0120 citations